Advanced search
Start date

Effect and mechanism of ketoconazole on prolactin, GH, ACTH, LH e FSH release by tumoral rat/mouse anterior pituitary cells in vitro

Grant number: 11/10582-1
Support Opportunities:Regular Research Grants
Duration: September 01, 2011 - August 31, 2013
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal Investigator:Marcello Delano Bronstein
Grantee:Marcello Delano Bronstein
Host Institution: Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil


Ketoconazole, antifungal agent, which revealed a potent inhibitor of adrenal steroidogenesis, can be used in the management of Cushing's disease when it is not controlled by surgical procedure and/or radiotherapy. Although it was expected that, with the reduction of serum cortisol levels and urinary occurrance elevation of plasma ACTH, this fact is often not observed. A hypothesis to explain this finding would be additional share of ketoconazole on the tumor pituitary adrenocorticotropic.In fact, some studies in the 1980s suggested action of ketoconazole in anterior pituitary cells . Our study aims to approach this topic, evaluating the effect of ketoconazole in the hormone secretion in vitro of lineages of pituitary tumor 's secreting hormones (prolactin, GH, FSH, LH, ACTH), as well as to evaluate the expression of genes involved in apoptosis and replication of DNA by the PCR technique in real time, before and after the incubation of the ketoconazole in culture medium. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.